IVALP-XR-750 10X10

About

IVALP-XR-750 is an extended-release formulation of valproic acid (or divalproex sodium), an anticonvulsant and mood-stabilizing medication. Its primary mechanism of action involves increasing the levels of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that helps to calm excessive electrical activity. This action contributes to its efficacy in controlling various types of seizures and stabilizing mood in bipolar disorder. The extended-release formulation allows for once-daily dosing, which can improve patient adherence and provide more consistent drug levels throughout the day.

Beyond its role in epilepsy and bipolar disorder, valproic acid is also utilized for the prophylaxis of migraine headaches. Its broad therapeutic profile stems from its ability to modulate neuronal excitability through multiple pathways, including effects on voltage-gated sodium channels and T-type calcium channels. Regular monitoring of blood levels and liver function is often necessary to ensure optimal therapeutic effect and minimize potential adverse reactions, particularly given its narrow therapeutic index.

Uses

• Treatment of various seizure types in epilepsy
• Management of manic episodes associated with bipolar disorder
• Prophylaxis of migraine headaches
• Adjunctive therapy for certain neuropathic pain conditions (off-label)

Directions For Use

Take orally, usually once daily with food to minimize gastrointestinal upset. Do not crush, chew, or break the extended-release tablets.

Benefits

• Effective for a broad spectrum of seizure disorders
• Proven efficacy as a mood stabilizer in bipolar disorder
• Reduces frequency and severity of migraine headaches
• Extended-release formulation allows for convenient once-daily dosing
• Helps to stabilize neuronal activity in the brain
• Well-established medication with extensive clinical experience

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Tremor
• Sedation
• Hair loss (alopecia)
• Weight gain
• Thrombocytopenia (low platelet count)
• Liver dysfunction (hepatotoxicity)
• Pancreatitis (inflammation of the pancreas)
• Birth defects (e.g., neural tube defects)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can increase CNS depression and potentially exacerbate liver toxicity.
• Pregnancy - High risk of birth defects (e.g., neural tube defects, developmental delays). Use only if benefits clearly outweigh risks, with folate supplementation.
• Breastfeeding - Generally considered compatible, but monitor infant for sedation, feeding difficulties, or liver issues. Consult your doctor.
• Liver - Contraindicated in severe hepatic dysfunction. Monitor liver function closely, especially in children and during the initial months of therapy.
• Kidney - Generally safe in renal impairment, but monitor for hyperammonemia. Dose adjustment is usually not required.
• Lung - No specific direct lung effects, but monitor for signs of hypersensitivity reactions that may involve multiple organ systems.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.